Effect of State Vaccine-Financing Strategy on Hepatitis B Immunization in Hospital Nurseries

Cabana, Michael D.; Aiken, Kimberly D.; Davis, Matthew M.; Freed, Gary L.; Clark, Sarah J.

doi:10.1367/1539-4409(2002)002<0367:eosvfs>2.0.co;2

Cited by 5 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As less than 5% of middle school students in allowing states claim a philosophic exemption [40], these exemptions may not affect immunization coverage at the state level. Also, in contrast to previous studies [23,24], we did not find universal purchase of vaccines to be associated with adolescent immunization coverage. This may be because universal purchase of vaccines is most beneficial for those who are uninsured or whose insurance does not cover the full cost of immunizations.…”

Section: Discussioncontrasting

confidence: 99%

“…Physician practices [8 -10], financial barriers [9 -11], and infrequent preventive health visits [9 -12] all play a role. State policies, such as mandating vaccination prior to school entry [13][14][15][16][17][18][19], not offering philosophic exemptions from vaccine mandates [20 -22], and providing universal purchase of vaccines [23,24] have been shown to be associated with higher vaccine coverage. Previous studies of strategies to improve immunization rates among adolescents have been limited by focusing on a single city or state [15,16,19,24] or by evaluating a single policy [14,17,20 -23].…”

mentioning

confidence: 99%

See 1 more Smart Citation

The Impact of State Policies on Vaccine Coverage by Age 13 in an Insured Population

Olshen

Mahon

Wang

et al. 2007

Journal of Adolescent Health

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 99%

mentioning

confidence: 99%

The Impact of State Policies on Vaccine Coverage by Age 13 in an Insured Population

Olshen

Mahon

Wang

et al. 2007

Journal of Adolescent Health

View full text Add to dashboard Cite

“…41,42 Despite the published preference by the ACIP and the AAP for initiation of the hepatitis B vaccine series at birth for all infants, and the availability of pediatric hepatitis B vaccines that no longer contain preservatives, increasing birthdose coverage may be difficult. Challenges in tracking and reimbursement are barriers to giving the birth dose in hospitals, 43 as is a growing preference among pediatricians for multipleantigen vaccinations, which cannot be given at birth. 44 However, administration of a single-antigen hepatitis B birth dose followed by combination vaccines for subsequent doses is safe and effective.…”

Section: Commentmentioning

confidence: 99%

Impact of Thimerosal-Related Changes in Hepatitis B Vaccine Birth-Dose Recommendations on Childhood Vaccination Coverage

Luman

Fiore²,

Strine³

et al. 2004

JAMA

View full text Add to dashboard Cite

ContextIn July 1999, the longstanding preference to begin hepatitis B vaccination of all US infants at birth was temporarily suspended because of concerns about exposure to mercury contained in the vaccine preservative thimerosal. The suspension was lifted in September 1999 when preservative-free hepatitis B vaccine became available.Objective To determine the effects of changes in recommendations regarding administration of a hepatitis B birth dose on vaccination coverage. Design, Setting, and Participants Cohort analysis of vaccination status of 41589 US children born before, during, and after the recommendation to suspend the birth dose.Main Outcome Measures Association between birth cohort and age at receipt of hepatitis B vaccine dose 1, and receipt by 19 months of age of all recommended vaccines. ResultsThe proportion of US infants who received dose 1 of hepatitis B vaccine at birth declined from 47% among those born 7 to 12 months before the suspension to 11% among those born during the suspension. Birth-dose coverage remained significantly lower in the year after the suspension was lifted (23% in the first 6 months and 33% in months 7-12). Coverage with 3 doses of hepatitis B vaccine by 19 months of age declined from 88% among those born 7 to 12 months before the suspension to 81% among those born during the suspension and 85% among those born in the 6 months after the suspension, but returned to baseline levels for those born 7 to 12 months after the suspension was lifted. These reductions represent 750000 fewer newborns vaccinated during 2000 compared with 1998, and an excess 182000 children undervaccinated for hepatitis B at 19 months of age compared with 1998 coverage levels. Coverage with other recommended vaccinations did not decline over this time.Conclusions Reductions in hepatitis B vaccine birth-dose coverage persisted after recommendations were made to resume previous newborn vaccination practices. Although the recommendation to complete the series by 19 months of age was never changed, infants born between July and December 1999 were less likely to have completed the series by 19 months, compared with infants born during the previous year. The lack of impact on other vaccinations suggests that public confidence in immunization remained strong.

show abstract

“…Many studies have noted that improved reimbursement to primary care providers (often within the Vaccine for Children Program) seems to improve vaccination coverage. [30][31][32][33][34][35][36][37][38] An expanded recommendation would need to be complemented by appropriate reimbursement by Vaccines for Children Program and private insurers.…”

Section: Reimbursementmentioning

confidence: 99%

The Feasibility of Universal Influenza Vaccination for Infants and Toddlers

Humiston¹,

Szilâgyi²,

Iwane³

et al. 2004

Arch Pediatr Adolesc Med

View full text Add to dashboard Cite

show abstract

Effect of State Vaccine-Financing Strategy on Hepatitis B Immunization in Hospital Nurseries

Cited by 5 publications

References 13 publications

The Impact of State Policies on Vaccine Coverage by Age 13 in an Insured Population

The Impact of State Policies on Vaccine Coverage by Age 13 in an Insured Population

Impact of Thimerosal-Related Changes in Hepatitis B Vaccine Birth-Dose Recommendations on Childhood Vaccination Coverage

The Feasibility of Universal Influenza Vaccination for Infants and Toddlers

Contact Info

Product

Resources

About